Teva Pharmaceutical Industries LimitedTEVANYSE
Loading
Debt Growth Recovery in ProgressRecovering
Percentile Rank87
5Y CAGR+7.8%
Year-over-Year Change
Year-over-year debt growth rate
5Y CAGR
+7.8%/yr
Long-term compound
Percentile
P87
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 1.70% |
| Q3 2025 | -2.47% |
| Q2 2025 | 3.45% |
| Q1 2025 | -6.31% |
| Q4 2024 | -6.20% |
| Q3 2024 | 1.87% |
| Q2 2024 | -5.10% |
| Q1 2024 | -1.07% |
| Q4 2023 | -0.71% |
| Q3 2023 | -3.42% |
| Q2 2023 | -0.10% |
| Q1 2023 | -2.43% |
| Q4 2022 | -0.27% |
| Q3 2022 | -3.71% |
| Q2 2022 | -3.68% |
| Q1 2022 | -0.64% |
| Q4 2021 | -2.95% |
| Q3 2021 | -5.49% |
| Q2 2021 | 0.59% |
| Q1 2021 | -3.68% |
| Q4 2020 | 1.17% |
| Q3 2020 | -2.20% |
| Q2 2020 | 0.62% |
| Q1 2020 | -3.03% |
| Q4 2019 | 0.02% |
| Q3 2019 | -6.23% |
| Q2 2019 | 0.36% |
| Q1 2019 | 0.46% |
| Q4 2018 | -1.94% |
| Q3 2018 | -2.47% |
| Q2 2018 | -1.67% |
| Q1 2018 | -5.31% |
| Q4 2017 | -6.42% |
| Q3 2017 | -1.00% |
| Q2 2017 | 1.20% |
| Q1 2017 | -3.25% |
| Q4 2016 | -2.86% |
| Q3 2016 | 237.56% |
| Q2 2016 | 7.04% |
| Q1 2016 | 2.33% |